We confirmed cath-D direct involvement in SPARC proteolysis also by using a mammary cancer cell line derived from tamoxifen-inducible CreERT2,Ctsdfl/flmice 45 crossed with the transgenic MMTV-PyMT mouse model of metastatic BC 46 (Figure 4F). The gene discussed is SPARC; the disease is breast cancer.